SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GFIH Graham-Field Health Prod

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Frank Perlmutter who wrote (34)4/29/1998 3:11:00 PM
From: Steve Rolfe   of 84
 
Stephens Inc. Analysis
Graham-Field Health Products, Inc. (GFI-NYSE) April 16, BUY

Company Fundamentals: ú One stop supplier; broad product line ú Service to customer will allow for increased market share ú Only company of its kind-niche strategy ú Efficient distribution strategy offers value-added services like same-day shipping and "paper-less" ordering Industry Fundamentals: ú Managed care dominates healthcare industry ú Trends are to improve product movement efficiencies, order management efficiencies and information sharing ú Cost emphasis is driving vendor/provider/distributor partnerships and consolidation
Valuation: ú We believe the stock is very cheap, currently selling at 58% of 1997 Fiscal Year end Book value per share, at 61% of our estimated 1998 sales per share and 9.6X our 1999 EPS estimate of $0.77.

Earnings Outlook: ú We are confident that the Company is on track to hit our operating EPS estimate of $0.01 for 1Q. ú We expect a 221% increase in 1999 to $0.77 from our estimated $0.24 in 1998.Market Psychology: ú Stock was severely impacted by 4Q earnings miss including acquisition integration charges. ú Solid fundamentals lead to market regaining confidence. ú Continually watching acquisition integration.

Recent Developments: ú Company filed 10K yesterday, including solid combined balance sheet (with Fuqua) for 1997 year end. ú GFI's banks amended financial covenants on its $100 million credit facility (waiving the covenants based on trailing 4Q EBIT levels that the Company was in default). ú The Company negatively surprised investors with lower than expected 4Q EPS, which were related to the integration of seven acquisitions made at end of 1996 and 1997.Considerations: ú Ability to build information systems to integrate seven acquisitions made in 1997. ú Ability to return to consistent profitability. ú Continued Medicare reimbursement cuts could lead to operating margin pressure.

Catalyst: ú Hit or beat earnings expectations for the next several quarters. ú Visible integration improvements (i.e. a centralized information system installed as well as other distribution efficiencies completed). ú Return to growth strategy in 1999 (i.e. accelerated roll-out of GF Express and potential additional acquisition growth).

Company Description: Graham-Field Health Products, Inc., headquartered in Hauppauge, New York, is a leading manufacturer and distributor in the healthcare industry, servicing both the medical/surgical and the home healthcare markets. GFI offers the most comprehensive line of healthcare products available from a single supplier. With the acquisition of Everest and Jennings, GFI has positioned itself as one of the leading manufacturers of durable medical equipment in North America.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext